Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

IL-17A influences essential functions of the monocyte / macrophage lineage and is involved in advanced murine and human atherosclerosis


ABSTRACT: Atherosclerosis is a chronic inflammatory disease. Lesion progression is primarily mediated by cells of the monocyte/macrophage lineage. Interleukin-17A is a pro-inflammatory cytokine, which modulates immune cell trafficking and is involved inflammation in (auto)immune and infectious diseases. But the role of IL-17A still remains controversial. In the current study we investigated effects of IL-17A on advanced murine and human atherosclerosis, the common disease phenotype in clinical care. 26-weeks old apolipoprotein E-deficient (Apoe-/-) mice were fed a standard chow diet and treated either with IL-17A mAb (n=15) or irrelevant immunoglobulin (n=10) for 16 weeks. Furthermore, essential mechanisms of IL-17A in atherogenesis were studied in vitro. Inhibition of IL-17A markedly prevented atherosclerotic lesion progression (P=0.001) by reducing inflammatory burden and cellular infiltration (P=0.01) and improved lesion stability (P=0.01). In vitro experiments showed that IL-17A plays a role in chemoattractance, monocyte adhesion, sensitization of antigen-presenting cells toward pathogen-derived TLR4 ligands. Also, IL-17A induced a unique transcriptome pattern in monocyte-derived macrophages distinct from known macrophage types. Stimulation of human carotid plaque tissue ex vivo with IL-17A induced a pro-inflammatory milieu and up-regulation of molecules expressed by the IL-17A-induced macrophage subtype. We here show for the first time that functional blockade of IL-17A prevents atherosclerotic lesion progression and induces plaque stabilization in advanced lesions in Apoe-/- mice. The underlying mechanisms involve reduced inflammation and distinct effects of IL-17A on monocyte / macrophage lineage. In addition, translational experiments underline the relevance for the human system. Effects of IL-17A on human monocyte-derived macrophages were assessed (n=2 per group).

ORGANISM(S): Homo sapiens

SUBMITTER: Christian Gleissner 

PROVIDER: E-GEOD-60824 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis.

Erbel Christian C   Akhavanpoor Mohammadreza M   Okuyucu Deniz D   Wangler Susanne S   Dietz Alex A   Zhao Li L   Stellos Konstantinos K   Little Kristina M KM   Lasitschka Felix F   Doesch Andreas A   Hakimi Maani M   Dengler Thomas J TJ   Giese Thomas T   Blessing Erwin E   Katus Hugo A HA   Gleissner Christian A CA  

Journal of immunology (Baltimore, Md. : 1950) 20140926 9


Atherosclerosis is a chronic inflammatory disease. Lesion progression is primarily mediated by cells of the monocyte/macrophage lineage. IL-17A is a proinflammatory cytokine, which modulates immune cell trafficking and is involved inflammation in (auto)immune and infectious diseases. But the role of IL-17A still remains controversial. In the current study, we investigated effects of IL-17A on advanced murine and human atherosclerosis, the common disease phenotype in clinical care. The 26-wk-old  ...[more]

Similar Datasets

2011-04-16 | E-GEOD-28649 | biostudies-arrayexpress
2015-03-31 | E-GEOD-53163 | biostudies-arrayexpress
2014-10-01 | GSE60824 | GEO
2016-03-08 | E-GEOD-77719 | biostudies-arrayexpress
2008-06-16 | E-GEOD-8515 | biostudies-arrayexpress
2022-12-02 | PXD036366 | Pride
2016-03-08 | E-GEOD-77172 | biostudies-arrayexpress
2018-03-31 | E-MTAB-6547 | biostudies-arrayexpress
2015-12-17 | E-GEOD-71248 | biostudies-arrayexpress
2013-01-18 | E-GEOD-43595 | biostudies-arrayexpress